{
 "schema_version": "014.v1",
 "company": {
  "company_id": "co:cik:0001782223",
  "name": "Pyxis Oncology, Inc.",
  "names": [
   {
    "name": "Pyxis Oncology, Inc.",
    "kind": "legal",
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0001782223",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-22T09:12:08Z",
     "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
    }
   }
  ],
  "granularity": "LEGAL_ENTITY",
  "identifiers": [
   {
    "type": "CIK",
    "value": "1782223",
    "join": "id",
    "join_method": "id:sec-anchor",
    "registry_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001782223",
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0001782223",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-22T09:12:08Z",
     "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
    }
   },
   {
    "type": "TICKER",
    "value": "PYXS",
    "join": "id",
    "join_method": "SEC company record",
    "registry_url": "https://data.sec.gov/submissions/CIK0001782223.json",
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-22T09:12:08Z",
     "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
    }
   },
   {
    "type": "EIN",
    "value": "831160910",
    "join": "id",
    "join_method": "carried on the SEC-anchored record",
    "registry_url": null,
    "evidence": {
     "source": "SEC EDGAR / IRS",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0001782223",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-22T09:12:08Z",
     "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
    }
   },
   {
    "type": "CUSIP",
    "value": "747324101",
    "join": "id",
    "join_method": "carried on the SEC-anchored record",
    "registry_url": null,
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0001782223",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-22T09:12:08Z",
     "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
    }
   }
  ],
  "addresses": [
   {
    "kind": "business",
    "text": "321 HARRISON AVENUE, BOSTON, MA, 02118",
    "country": "US",
    "evidence": {
     "source": "SEC EDGAR company profile",
     "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-22T09:12:08Z",
     "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
    }
   }
  ],
  "classifications": [
   {
    "scheme": "SIC",
    "code": "2834",
    "description": "Pharmaceutical Preparations",
    "evidence": {
     "source": "SEC EDGAR company profile",
     "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-22T09:12:08Z",
     "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
    }
   }
  ],
  "status": [
   {
    "registry": "SEC EDGAR filer type",
    "status": "operating",
    "evidence": {
     "source": "SEC EDGAR company profile",
     "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-22T09:12:08Z",
     "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
    }
   }
  ]
 },
 "facts": [
  {
   "section": "filed_figures",
   "label": "SEC entity type",
   "value": "operating",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "SIC industry",
   "value": "2834 Pharmaceutical Preparations",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "State of incorporation",
   "value": "DE",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Fiscal year end (MMDD)",
   "value": "1231",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Business address",
   "value": "321 HARRISON AVENUE, BOSTON, MA, 02118",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Exchanges",
   "value": "Nasdaq",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0001782223.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Revenue (fiscal year ended 2025-12-31)",
   "value": 13858000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL Revenues",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526118532/0001193125-26-118532-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Net income (loss) (fiscal year ended 2025-12-31)",
   "value": -79621000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL NetIncomeLoss",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526118532/0001193125-26-118532-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Total assets (at 2025-12-31)",
   "value": 91520000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL Assets",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526118532/0001193125-26-118532-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Stockholders' equity (at 2025-12-31)",
   "value": 53408000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL StockholdersEquity",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526118532/0001193125-26-118532-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Cash and cash equivalents (at 2025-12-31)",
   "value": 15422000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL CashAndCashEquivalentsAtCarryingValue",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526118532/0001193125-26-118532-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Operating cash flow (fiscal year ended 2025-12-31)",
   "value": -63502000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL NetCashProvidedByUsedInOperatingActivities",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526118532/0001193125-26-118532-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)",
   "value": 9000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526118532/0001193125-26-118532-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Operating lease liabilities (at 2025-12-31)",
   "value": 18650000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL OperatingLeaseLiability",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526118532/0001193125-26-118532-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Form D total offering amount (D filed 2021-03-22)",
   "value": 172499998,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "D",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000178222321000002/xslFormDX01/primary_doc.xml",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Form D total amount sold (D filed 2021-03-22)",
   "value": 172499998,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "D",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000178222321000002/xslFormDX01/primary_doc.xml",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Form D industry group",
   "value": "Other Health Care",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "D",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000178222321000002/xslFormDX01/primary_doc.xml",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Form D revenue range",
   "value": "Decline to Disclose",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "D",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000178222321000002/xslFormDX01/primary_doc.xml",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Form D date of first sale",
   "value": "2021-03-05",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "D",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000178222321000002/xslFormDX01/primary_doc.xml",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Latest 10-Q: Net income (loss)",
   "value": -19984000,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526448612/",
    "filing_id": "0001193125-26-448612",
    "filed_date": "2026-11-05",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "filed_figures",
   "label": "Latest 10-Q: Cash and cash equivalents",
   "value": 3856000,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526448612/",
    "filing_id": "0001193125-26-448612",
    "filed_date": "2026-11-05",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-19)",
   "value": "On November 18, 2026, Pyxis Oncology, Inc. (the “Company”) issued a press release announcing updated data from its ongoing global Phase 1 monotherapy study of micvotabart pelidotin (MICVO) in patients with second-line and beyond recurrent/metastatic head and neck squamous cell carcinoma. On November 19, 2026, the Company made available on its website a related corporate presentation for use that day in its Late-Breaking Oral Presentation at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain. A copy of the press release is attached as Exhibit 99.1 and the corporate presentation is attached as Exhibit 99.2 to this Current Report on Form 8-K. The…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001193125-26-467780 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526467780/pyxs-20261118.htm",
    "filing_id": null,
    "filed_date": "2026-11-19",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 8.01, Other Events (filed 2026-11-19)",
   "value": "On November 18, 2026, the Company announced updated data from its ongoing global Phase 1 monotherapy study evaluating micvotabart pelidotin (MICVO) in patients with second-line and beyond (2L+) recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). The cutoff date for all data reported below is October 14, 2026. Updated MICVO Phase 1 Monotherapy Trial Results as of October 14, 2026 Table 1: Survival and Durability Data Categories October 2026 Median progression-free survival (mPFS), months 6.7 12-month overall survival (OS) probability, % 81% Median duration of response (mDOR), months 9.2 Data as of 14-Oct-2026 Table 2: Response Data Categories Groups (N) October 2026…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001193125-26-467780 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526467780/pyxs-20261118.htm",
    "filing_id": null,
    "filed_date": "2026-11-19",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (filed 2026-11-13)",
   "value": "As discussed below under Item 5.07, on November 13, 2026 at Pyxis Oncology, Inc.’s (the “Company”) Special Meeting of Stockholders (the “Special Meeting”), the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to increase the number of authorized shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), from 190,000,000 shares to 380,000,000 shares (the “Authorized Share Increase”). On November 13, 2026, the Company filed a Certificate of Amendment to the Certificate of Incorporation (the “Charter Amendment”) with the Secretary of State of the State of Delaware to…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001193125-26-460698 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526460698/pyxs-20261113.htm",
    "filing_id": null,
    "filed_date": "2026-11-13",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 5.07, Submission of Matters to a Vote of Security Holders (filed 2026-11-13)",
   "value": "On November 13, 2026, the Company held the Special Meeting at 10:00 a.m. Eastern Standard Time in a virtual format via live audio webcast. As of October 8, 2026, the Company’s record date, there were a total of 119,583,637 shares of Common Stock outstanding and entitled to vote at the Special Meeting. At the beginning of the Special Meeting, 84,997,679 shares of Common Stock were present virtually, in person or by proxy, and, therefore, a quorum was present. Two items of business were acted upon by the stockholders at the Special Meeting. The final results for the votes regarding each proposal are set forth below. Proposal One: Approval of the Authorized Share Increase The stockholders…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001193125-26-460698 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526460698/pyxs-20261113.htm",
    "filing_id": null,
    "filed_date": "2026-11-13",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-05)",
   "value": "On November 5, 2026, Pyxis Oncology, Inc. (“the Company”) issued a press release announcing its financial results for the quarter ended September 30, 2026 and provided a corporate update. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 2.02 of this Current Report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing with the U.S. Securities and Exchange Commission made by…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001193125-26-448604 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526448604/pyxs-20261105.htm",
    "filing_id": null,
    "filed_date": "2026-11-05",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #1 (13F as filed): GordonMD Global Investments LP",
   "value": 30174976,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2039349/000091957426005398/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #2 (13F as filed): Pfizer Inc",
   "value": 19480773,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000102/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #3 (13F as filed): Laurion Capital Management LP",
   "value": 14751673,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1390202/000139020226000016/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #4 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC",
   "value": 6248751,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2100119/000210011926001527/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #5 (13F as filed): Atle Fund Management AB",
   "value": 2909041,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1381843/000138184326000005/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #6 (13F as filed): BlackRock, Inc.",
   "value": 2612481,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2012383/000201238326003238/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #7 (13F as filed): Palo Alto Investors LP",
   "value": 2601474,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1306923/000207367926000102/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #8 (13F as filed): MARSHALL WACE, LLP",
   "value": 2499936,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1318757/000131875726000010/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #9 (13F as filed): RENAISSANCE TECHNOLOGIES LLC",
   "value": 2324418,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1037389/000103738926000059/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #10 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC",
   "value": 1782698,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1214717/000121471726000008/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  }
 ],
 "changes": [
  {
   "date": "2026-11-19",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 7.01 Regulation FD disclosure; Item 8.01 other event",
   "freshness": "red",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526467780/pyxs-20261118.htm",
    "filing_id": null,
    "filed_date": "2026-11-19",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-11-13",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 5.03 charter or bylaw amendment; Item 5.07 shareholder vote",
   "freshness": "amber",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526460698/pyxs-20261113.htm",
    "filing_id": null,
    "filed_date": "2026-11-13",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-11-05",
   "type": "Filing",
   "summary_as_filed": "10-Q filed",
   "freshness": "amber",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526448612/pyxs-20260930.htm",
    "filing_id": null,
    "filed_date": "2026-11-05",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-11-05",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations",
   "freshness": "amber",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526448604/pyxs-20261105.htm",
    "filing_id": null,
    "filed_date": "2026-11-05",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-10-21",
   "type": "Filing",
   "summary_as_filed": "DEF 14A filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526427882/def_14a_oct_26.htm",
    "filing_id": null,
    "filed_date": "2026-10-21",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-10-09",
   "type": "Filing",
   "summary_as_filed": "PRE 14A filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526419208/pre_14a_october_26.htm",
    "filing_id": null,
    "filed_date": "2026-10-09",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-10-01",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 1.01 material agreement; Item 8.01 other event; Item 9.01 exhibits",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000143774926031767/pyxs20261001_8k.htm",
    "filing_id": null,
    "filed_date": "2026-10-01",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-10-01",
   "type": "Filing",
   "summary_as_filed": "424B5 filed (FORM 424B5)",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000143774926031667/pyxs20260930_424b5.htm",
    "filing_id": null,
    "filed_date": "2026-10-01",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-09-29",
   "type": "Filing",
   "summary_as_filed": "424B5 filed (FORM 424B5)",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000143774926031480/pyxs20260909_424b5.htm",
    "filing_id": null,
    "filed_date": "2026-09-29",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-09-29",
   "type": "Filing",
   "summary_as_filed": "424B5 filed (FORM 424B5)",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000143774926031470/pyxs20260909c_424b5.htm",
    "filing_id": null,
    "filed_date": "2026-09-29",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-09-09",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526385901/pyxs-20260909.htm",
    "filing_id": null,
    "filed_date": "2026-09-09",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-09-08",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526384386/pyxs-20260903.htm",
    "filing_id": null,
    "filed_date": "2026-09-08",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-08-28",
   "type": "Filing",
   "summary_as_filed": "424B2 filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526372221/s-3-424b2.htm",
    "filing_id": null,
    "filed_date": "2026-08-28",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-08-27",
   "type": "Filing",
   "summary_as_filed": "EFFECT filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/999999999526002786/xslEFFECTX01/primary_doc.xml",
    "filing_id": null,
    "filed_date": "2026-08-27",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-08-20",
   "type": "Filing",
   "summary_as_filed": "S-3 filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526359246/pyxs-20260820.htm",
    "filing_id": null,
    "filed_date": "2026-08-20",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-08-13",
   "type": "Filing",
   "summary_as_filed": "10-Q filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526347913/pyxs-20260630.htm",
    "filing_id": null,
    "filed_date": "2026-08-13",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-08-13",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526347911/pyxs-20260813.htm",
    "filing_id": null,
    "filed_date": "2026-08-13",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-07-02",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 7.01 Regulation FD disclosure",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526294613/pyxs-20260630.htm",
    "filing_id": null,
    "filed_date": "2026-07-02",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-06-15",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 5.07 shareholder vote",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526271137/pyxs-20260615.htm",
    "filing_id": null,
    "filed_date": "2026-06-15",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-05-14",
   "type": "Filing",
   "summary_as_filed": "10-Q filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526222843/pyxs-20260331.htm",
    "filing_id": null,
    "filed_date": "2026-05-14",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-05-14",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526222818/pyxs-20260514.htm",
    "filing_id": null,
    "filed_date": "2026-05-14",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-04-30",
   "type": "Filing",
   "summary_as_filed": "ARS filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526194065/2026_ars.pdf",
    "filing_id": null,
    "filed_date": "2026-04-30",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-04-30",
   "type": "Filing",
   "summary_as_filed": "DEFA14A filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526194051/2026proxy_defa14a.htm",
    "filing_id": null,
    "filed_date": "2026-04-30",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-04-30",
   "type": "Filing",
   "summary_as_filed": "DEF 14A filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526194032/2026_pyxs-14a.htm",
    "filing_id": null,
    "filed_date": "2026-04-30",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  },
  {
   "date": "2026-04-30",
   "type": "Filing",
   "summary_as_filed": "8-K/A filed: Item 5.02 officer or director change",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1782223/000119312526193940/pyxs-20260206.htm",
    "filing_id": null,
    "filed_date": "2026-04-30",
    "retrieved_at": "2026-11-22T09:12:08Z",
    "content_hash": "f0ce087700ba7d77f5fbe14e24ed39440d4b6084f4cdb5e62d5f43e3c00dcc1a"
   }
  }
 ],
 "connections": [],
 "screening": [
  {
   "list": "World Bank debarment list",
   "result": "not_checked",
   "matched_name": null,
   "match_basis": "not checked: link-out only; the World Bank terms allow non-commercial use only and written consent for commercial reuse has been requested",
   "list_as_of": "2026-11-22",
   "evidence": {
    "source": "World Bank",
    "source_url": "https://www.worldbank.org/en/projects-operations/procurement/debarred-firms",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:32:32Z",
    "content_hash": null
   }
  }
 ],
 "open_in": [
  {
   "site": "TradingView",
   "url": "https://www.tradingview.com/symbols/NASDAQ-PYXS/"
  },
  {
   "site": "Yahoo Finance quote and chart",
   "url": "https://finance.yahoo.com/quote/PYXS/"
  },
  {
   "site": "Google Finance",
   "url": "https://www.google.com/finance/quote/PYXS:NASDAQ"
  },
  {
   "site": "Reuters search",
   "url": "https://www.reuters.com/site-search/?query=Pyxis%20Oncology%2C%20Inc."
  },
  {
   "site": "Yahoo Finance news",
   "url": "https://finance.yahoo.com/quote/PYXS/news/"
  },
  {
   "site": "Google News search",
   "url": "https://news.google.com/search?q=Pyxis%20Oncology%2C%20Inc."
  },
  {
   "site": "Yahoo Finance analysis",
   "url": "https://finance.yahoo.com/quote/PYXS/analysis/"
  },
  {
   "site": "Nasdaq earnings",
   "url": "https://www.nasdaq.com/market-activity/stocks/pyxs/earnings"
  },
  {
   "site": "Yahoo Finance options",
   "url": "https://finance.yahoo.com/quote/PYXS/options/"
  },
  {
   "site": "Nasdaq option chain",
   "url": "https://www.nasdaq.com/market-activity/stocks/pyxs/option-chain"
  },
  {
   "site": "SEC EDGAR Form 4 filings",
   "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001782223&type=4&dateb=&owner=include&count=40"
  },
  {
   "site": "OpenInsider",
   "url": "http://openinsider.com/PYXS"
  },
  {
   "site": "WhaleWisdom",
   "url": "https://whalewisdom.com/stock/pyxs"
  },
  {
   "site": "Nasdaq short interest",
   "url": "https://www.nasdaq.com/market-activity/stocks/pyxs/short-interest"
  },
  {
   "site": "Search X for the company's verified account",
   "url": "https://x.com/search?q=Pyxis%20Oncology%2C%20Inc.&f=user"
  },
  {
   "site": "World Bank debarred firms (check on the World Bank site)",
   "url": "https://www.worldbank.org/en/projects-operations/procurement/debarred-firms"
  }
 ],
 "limits": [
  "Seraphix is not a consumer reporting agency. Reports are not consumer reports and may not be used for employment, credit, insurance, housing or any FCRA purpose.",
  "No credit scores and no trade-payment data: Seraphix is not a credit bureau.",
  "Principals (officers) are role-level only until counsel rules.",
  "UCC filings, liens and bankruptcy are gaps: not covered yet.",
  "Name-matched joins are dashed possible matches until the accuracy score (due 11-21).",
  "Data is as of the stamped time on this page.",
  "Organizations only. No individuals.",
  "Court records: not covered yet",
  "UCC filings, liens, bankruptcy: not covered yet",
  "Exhibit 21 subsidiaries: not held yet",
  "WARN notices: not held yet",
  "Legislative exposure: not covered yet",
  "Principals: role-level only until counsel rules",
  "No H-1B LCA filed under EIN 831160910 in FY2026 Q3",
  "H-1B LCAs only (H-1B1 and E-3 excluded); one fiscal quarter (FY2026 Q3) only, earlier quarters not loaded",
  "No Form 5500 plan filed under sponsor EIN 831160910 for plan year 2025",
  "Plan year 2025 only (EFAST2 'Latest' file); earlier years not loaded",
  "No Form 990 found for EIN 831160910",
  "USAspending: no recipient whose SAM legal name and address match this SEC filer"
 ],
 "provenance": {
  "assembled_at": "2026-11-22T09:32:32Z",
  "sources_n": 2,
  "seconds": 0.33,
  "evidence_bundle_url": "https://seraphixsystems.com/company/1782223.evidence.json",
  "bundle_hash": "5f9beadfb37ea3e0b4b01bd373a3004427dbf6c21472da1dc9fa03b47ba2cf4f",
  "not_a_consumer_report": true
 }
}